Cargando...
Conjugating Prussian blue nanoparticles onto antigen-specific T cells as a combined nanoimmunotherapy
AIM: To engineer a novel nanoimmunotherapy comprising Prussian blue nanoparticles (PBNPs) conjugated to antigen-specific cytotoxic T lymphocytes (CTL), which leverages PBNPs for their photothermal therapy (PTT) capabilities and Epstein–Barr virus (EBV) antigen-specific CTL for their ability to traff...
Gardado en:
| Publicado en: | Nanomedicine (Lond) |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Future Medicine Ltd
2016
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4941545/ https://ncbi.nlm.nih.gov/pubmed/27389189 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2217/nnm-2016-0160 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|